Ethyl cysteinate dimer (ECD) in chronic cerebral infarction: Comparison with hexamethylpropylene amine oxime (HMPAO);L'ethyl cysteinate dimer (ECD) dans l'accident vasculaire cerebral chronique: Comparaison avec l'hexamethylpropylene amine oxime (HMPAO)

Schweizer Archiv fur Neurologie und Psychiatrie

Volumn 148, Issue 2, 1997, Pages 64-68

  Lövblad, Karl Olof ^a,b,d   Lebtahi, Nour Eddine ^b   Bogousslavsky, Julien ^b   Curtin, François ^c   Bischof Delaloye, Angelika ^b  

^a Hopital de l'Ile   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c IUPG   (Switzerland)

^d Hôpital de l'Ile   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CHRONIC BRAIN DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE;

EID: 0030863912     PISSN: 02587661     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Lövblad KO, Ozdoba C, Remonda L, Zambaz BD, Schroth G: Diagnostic tomodensitométrique de thromboses basilaires aigues. Schweiz med Wochenschr 1995; 125: 20-25.
2. Lassen NA, Symon L, Baron JC: Problèmes actuels en neurologie, Volume 1: Pénombre et ischémie cérébrale Paris, Londres: John Libbey, 1986.
3. Moretti JL, Caglar M, Weinmann P: Cerebral perfusion imaging tracers for SPECT: Which one to choose? J Nucl Med 1995; 36: 359-363.
4. Orlandi C, Crane PD, Platts SH, Walovitch RC: Regional cerebral blood flow and distribution of 99m-Tc-Ethyl Cysteinate Dimer in nonhuman primates. Stroke 1990; 21: 1059-1063.
5. Vallabhajosula S, Zimmerman RE, Picard M, Stritzke P, Mena I, Hellman RS, Tikofsky RS, Stabin MG, Morgan RA, Goldsmith SJ; Technetium-99m ECD: A new brain imaging agent:: In vivo kinetics and biodistribution studies in normal human subjects. J Nucl Med 1989; 30: 599-604.
6. Walovitch RC, Till TC, Garrity ST, Cheesman EH, Burgess BA, O'Leary DH, Watson AD, Ganey MV, Morgan RA, Williams SJ: Characterization of Technetium-99m-1,1-ECD for brain perfusion imaging, Part 1: Pharmacology of Technetium-99m ECD in non-human primates. J Nucl med 1989; 30: 1892-1901.
7. Walovitch RC, Franceschi M, Picard M, Hall KM, Makuch J, Watson MW, Zimmerman RE, Watson AD, Ganey MV, Williams SJ, Kolman BL: Metabolism of 99m-Tc-1,1-ethyl Cysteinate Dimer in healthy volunteers. Neuropharmacology 1991; 30: 283-292.
8. Holman BL, Hellman RS, Goldsmith SJ, Mena IG, Leveille J, Gereardi PG, Moretti JL, Bischof-Delaloye A, Hill TC, Rigo PM, Van Heertum RL, Ell PJ, Buell U, De Roo MC, Morgan RA: Biodistribution, Dosimerty, and clinical evaluation of Technetium-99m Ethyl Cysteinate Dimer in normal subjects and in patients with chronic cerbral infarction. J Nucl Med 1989; 30: 1018-1024.
9. Matsuda H, Yagashita A, Tsuji S, Hisada K: A quantitative approach to Tc-99m ECD: a comparison with Tc-99m HMPAO. Eur J Nucl Med 1995; 22: 633-637.
10. Böck JC, Sander B, Hierholzer J, Haustein J, Scholz, Radke KH, Schrömer, Lanksch W, Felix R: Regionale Durchblutung bei intrakraniellen Tumoren: Vergleich der HMPAO-SPECT mit einem neuren magnetresonanztomographischen Verfahren. RöFo Fortscr. Röntgenstr. 1992; 157: 378-383.
11. Lassen NA: Imaging brain infarcts by singel photon emission tomography with new tracers. European J Nucl Med 1994; 21: 189-190.
12. Pupi A, Castagnoli A, De Cristofaro MT, Bacciottini L, Petti AR: Quantitative comparison between 99mTc HMPAO and 99mTc ECD: measurement of arterial input and brain retention. Eur J Nucl Med 1994; 21: 124-130.
13. Slosman DO, Jacquir M, Pugin J, Rüfenacht DA, Donath A, Polla BS: In vitro Study of HMPAO and ECD cellular retention. Schweiz Med Wochenschr 1995; 125: Suppl. 68: 25S.
14. Grunwald F, Menzel C, Pavics L, Bauer J, Hufnagel A, Reichmann K, Sakowski R, Elger CE, Biersack HJ: Ictal and interictal brain SPECT imaging in epilepsy using technetium 99m ECD. J Nucl Med 1994; 35: 1896-1901.
15. Leveille J, Demonceau G, Walovitch RC: Intrasubject comparison between technetium 99m ECD and technetium 99m HMPAO in healthy human subjects. J Nucl Med 1992; 33: 480-484.
16. Devous MD Sr, Payne JK, Lowe JL, Leroy RF: Comparison of technetium 99m ECD to Xenon 133 SPECT in normal controls and in patients with mild to moderate regional cerebral blood flow abnormalities. J Nucl Med 1993; 34: 754-761.
17. Tsuchida T, Nishizawa S, Yonekura Y, Sadato N, Iwasaki Y, Fujita T, Matoba N, Magata Y, Tamaki N, Konishi J: SPECT images of technetium 99m ethyl cysteinate dimer in cerebrovascular diseases: comparison with other cerebral perfusion tracers and PET. J Nucl med 1994; 35: 27-31.
18. Nakagawara J, Nakamura J, Takeda R, Okumura T, Seki T, Hayase K, Satoh K, Suematsu K: Assessment of postischemic reperfusion and diamox activation test in stroke using 99mTc ECD SPECT. J Cereb Blood Flow Metab 1994 Jan, 14 Suppl 1: S49-57.